3 articles for “Miltefosine”

Set a search alert

Research ArticleOpen accessEvery word in the titlePOST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINEVidyanand Rabi Das, Dharmendra Singh, Krishna Murti et al.Visceral Leishmaniasis (VL) or Kala-Azar (KA) is highly endemic in the Indian subcontinent particularly in Bihar. Post Kala-azar Dermal Leishmaniasis (PKDL) is a known reservoir for leishmania parasites for transmission of VL. The kala-azar elimination program was launched by the government of three countries of the Indian subcontinent in the year 2005, which aims to eliminate kala-azar by 2015 and … …American Journal of Infectious Diseases, Vol. 10, Issue 2 · 2 Apr 2014 · 7,583 accessesView PDF Cite

Research ArticleOpen accessIn the keywordsNEWER DRUGS FOR VISCERAL LEISHMANIASIS: A REVIEWKrishna Pandey, Dharmendra Singh, Sanjiva Bimal et al.Visceral Leishmaniasis (VL) is one of the most neglected tropical diseases worldwide. The diagnosis and treatment of this disease is quite complex. Sodium Antimony Gluconate (SAG) which used to be a very effective treatment has now developed resistance and is potentially a cardio-toxic drug. Pentamidine has now been discarded because of adverse effect of diabetes mellitus. Amphotericin-B is an effective … …American Journal of Infectious Diseases, Vol. 10, Issue 2 · 5 May 2014 · 7,133 accessesView PDF Cite

Case ReportOpen accessIn the abstractRelapsing Cutaneous Leishmaniasis in a Patient Treated with HumiraErik Otte, Mikael Christiansen, Eskild PetersenLeishmanias is an anthropozoonosis caused by the Leishmania protozoa. The manifestation of the disease varies depending on the type of Leishmania and the immunestatus of the patient. Tumor Necrosis Factor (TNF)-α antagonists were introduced in the late 1990s and have had a marked impact on rheumatic diseases. Tumor necrosis factor plays an important role in the immune systems defense against … …American Journal of Infectious Diseases, Vol. 11, Issue 1 · 9 Jun 2015 · 6,881 accessesView PDF Cite